Guidelines for Acromegaly Management: An Update

被引：541

作者：

Melmed, S. ^{[1
]}

Colao, A. ^{[2
]}

Barkan, A. ^{[3
]}

Molitch, M. ^{[4
]}

Grossman, A. B. ^{[5
]}

Kleinberg, D. ^{[6
]}

Clemmons, D. ^{[7
]}

Chanson, P. ^{[8
,9
]}

Laws, E. ^{[10
]}

Schlechte, J. ^{[11
]}

Vance, M. L. ^{[12
]}

Ho, K. ^{[13
]}

Giustina, A. ^{[14
]}

机构：

[1] Cedars Sinai Med Ctr, Cedars Sinai Res Inst, Dept Med, Los Angeles, CA 90048 USA

[2] Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80138 Naples, Italy

[3] Univ Michigan, Div Endocrinol & Metab, Med Ctr, Ann Arbor, MI 48109 USA

[4] Northwestern Univ, Endocrinol Clin, Feinberg Sch Med, Chicago, IL 60611 USA

[5] St Bartholomews Hosp, Dept Endocrinol, London EC1A 7BE, England

[6] NYU, Med Ctr, Dept Med, New York, NY 10016 USA

[7] Univ N Carolina, Div Endocrinol, Chapel Hill, NC 27599 USA

[8] Hop Bicetre, AP HP, Dept Endocrinol & Reprod Dis, F-94276 Le Kremlin Bicetre, France

[9] Univ Paris 11, F-94276 Le Kremlin Bicetre, France

[10] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA

[11] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA

[12] Univ Virginia, Dept Med, Charlottesville, VA 22904 USA

[13] Garvan Inst Med Res, Pituitary Res Unit, Sydney, NSW 2010, Australia

[14] Univ Brescia, Dept Internal Med, I-25121 Brescia, Italy

来源：

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2009年 / 94卷 / 05期

关键词：

GROWTH-FACTOR-I; GAMMA-KNIFE RADIOSURGERY; PREOPERATIVE OCTREOTIDE TREATMENT; ACTING SOMATOSTATIN ANALOGS; DOPAMINE AGONIST THERAPY; LONG-TERM EFFICACY; QUALITY-OF-LIFE; FOLLOW-UP; PITUITARY-ADENOMAS; TRANSSPHENOIDAL SURGERY;

D O I：

10.1210/jc.2008-2421

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: The Acromegaly Consensus Group reconvened in November 2007 to update guidelines for acromegaly management. Participants: The meeting participants comprised 68 pituitary specialists, including neurosurgeons and endocrinologists with extensive experience treating patients with acromegaly. Evidence/Consensus Process: Goals of treatment and the appropriate imaging and biochemical and clinical monitoring of patients with acromegaly were enunciated, based on the available published evidence. Conclusions: The group developed a consensus on the approach to managing acromegaly including appropriate roles for neurosurgery, medical therapy, and radiation therapy in the management of these patients. (J Clin Endocrinol Metab 94: 1509-1517, 2009)

引用

页码：1509 / 1517

页数：9

共 100 条

[1] A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years [J].

Abbassioun, K. ;

Amirjamshidi, A. ;

Mehrazin, M. ;

Khalatbary, I. ;

Keynama, M. ;

Bokai, H. ;

Abdollahi, M. .

SURGICAL NEUROLOGY, 2006, 66 (01) :26-31

[2] Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre [J].

Abe, T ;

Lüdecke, DK .

EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2001, 145 (02) :137-145

[3] Cabergoline in the treatment of acromegaly: A study in 64 patients [J].

Abs, R ;

Verhelst, J ;

Maiter, D ;

Van Acker, K ;

Nobels, F ;

Coolens, JL ;

Mahler, C ;

Beckers, A .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :374-378

[4]

Ahmed S, 1999, CLIN ENDOCRINOL, V50, P561

[5] Long-term effects of lanreotide SR and octreotide LAR® on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly [J].

Amato, G ;

Mazziotti, G ;

Rotondi, M ;

Iorio, S ;

Doga, M ;

Sorvillo, F ;

Manganella, G ;

Di Salle, F ;

Giustina, A ;

Carella, C .

CLINICAL ENDOCRINOLOGY, 2002, 56 (01) :65-71

[6] Growth hormone response during oral glucose tolerance test:: The impact of assay method on the estimation of reference values in patients with acromegaly and in healthy controls, and the role of gender, age, and body mass index [J].

Arafat, Ayman M. ;

Moehlig, Matthias ;

Weickert, Martin O. ;

Perschel, Frank H. ;

Purschwitz, Johannes ;

Spranger, Joachim ;

Strasburger, Christian J. ;

Schoefl, Christof ;

Pfeiffer, Andreas F. H. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2008, 93 (04) :1254-1262

[7] Gamma-knife radiosurgery in acromegaly: A 4-year follow-up study [J].

Attanasio, R ;

Epaminonda, P ;

Motti, E ;

Giugni, E ;

Ventrella, L ;

Cozzi, R ;

Farabola, M ;

Loli, P ;

Beck-Peccoz, P ;

Arosio, M .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (07) :3105-3112

[8] Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly [J].

Ayuk, J ;

Clayton, RN ;

Holder, G ;

Sheppard, MC ;

Stewart, PM ;

Bates, AS .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1613-1617

[9] Hormonal and metabolic effects of radiotherapy in acromegaly: Long-term results in 128 patients followed in a single center [J].

Barrande, G ;

Pittino-Lungo, M ;

Coste, J ;

Ponvert, D ;

Bertagna, X ;

Luton, JP ;

Bertherat, J .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (10) :3779-3785

[10] Wide variation in surgical outcomes for acromegaly in the UK [J].

Bates, P. R. ;

Carson, M. N. ;

Trainer, P. J. ;

Wass, J. A. H. .

CLINICAL ENDOCRINOLOGY, 2008, 68 (01) :136-142

← 1 2 3 4 5 6 7 8 9 10 →